Skip To The Main Content

Browse these ideas available for licensing that have the potential to improve lives while creating jobs to support and grow the region.

All technologies
 are listed as non-confidential technical summaries.

Technologies were generated by academic institutions, entrepreneurs, and corporations.

Click the Tech Search button below to have Whiteboard 2 Boardroom® staff complete a personalized search for innovations to license from our research institution partners.

The most recent innovations from our partners are featured separately and organized by category. All listings are updated as new technology opportunities become available. 

For assistance in connecting with, or attaining further information on any of these technologies, please contact us.

Novel Dual Targeting Biomarker for Prostate Cancer

Diagnosis and treatment information for prostate cancer remains a difficult problem. Current methods in diagnosis include some combination of rectal exam, blood analysis, MRI, CT, and ultrasound. Medical practitioners are often left with difficult decisions regarding which tests to order, both for discovery of prostate cancer cells as well as treatment. Much of the issues arise from a high rate of false positives that occur in the traditional PSA blood analysis test.

To combat these issues, researchers have begun creating efficient biomarker targeting compounds to be used in PET and SPECT scans. Visualizing cancerous growth has a number of advantages and can be both more accurate and meaningful than traditional diagnostic methods. Two of the most promising biomarkers for prostate cancer cells have been separately used successfully to diagnose prostate cancer.

However, it has recently been shown that these biomarkers have their own problems. The biomarker levels appear to change in patients based upon several factors. For instance, cancer growth patterns and the age of a tumor can affect levels. As a result, imaging based upon only one of the two biomarkers may be insufficient to capture the full range of prostate cancer, especially if a patient’s cancer has metastasized.



• Prostate Cancer

• Diagnostic

• Target Treatments



• Low Cost

• Flexible

• Simple



• Patent Application in Work

Additional Details


University of Missouri- Columbia

Intellectual Property Protection


Interested? Request More Information